Emergent Biosolutions
EBS
EBS
183 hedge funds and large institutions have $336M invested in Emergent Biosolutions in 2023 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 59 increasing their positions, 75 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
28% less capital invested
Capital invested by funds: $465M → $336M (-$129M)
30% less call options, than puts
Call options by funds: $1.02M | Put options by funds: $1.47M
Holders
183
Holding in Top 10
–
Calls
$1.02M
Puts
$1.47M
Top Buyers
| 1 | +$10.2M | |
| 2 | +$6.44M | |
| 3 | +$3.31M | |
| 4 |
PGCM
Prescott Group Capital Management
Tulsa,
Oklahoma
|
+$2.25M |
| 5 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$2.11M |
Top Sellers
| 1 | -$8.01M | |
| 2 | -$3.46M | |
| 3 | -$3.27M | |
| 4 |
D.E. Shaw & Co
New York
|
-$2.84M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$2.36M |